Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-11-14
DOI
10.3389/fonc.2016.00241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
- (2016) Miguel Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
- (2016) Richard Buus et al. JNCI-Journal of the National Cancer Institute
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
- (2016) Richard Buus et al. JNCI-Journal of the National Cancer Institute
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype
- (2015) Eleanor F. Need et al. BMC CANCER
- Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
- (2015) Brett Wallden et al. BMC Medical Genomics
- Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
- (2015) Aleix Prat et al. BMC Medicine
- Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial
- (2015) Shuzhen Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
- (2015) Tara Sanft et al. BREAST CANCER RESEARCH AND TREATMENT
- Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score
- (2015) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
- (2014) Torsten Nielsen et al. BMC CANCER
- Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer
- (2014) Mitsuchika Hosoda et al. BREAST CANCER RESEARCH AND TREATMENT
- Long-term impact of the 70-gene signature on breast cancer outcome
- (2014) C. A. Drukker et al. BREAST CANCER RESEARCH AND TREATMENT
- Hormonal Regulation of the Immune Microenvironment in the Mammary Gland
- (2014) Eleanor F. Need et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
- (2014) Renaud Sabatier et al. Molecular Cancer
- Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
- (2013) M. Gnant et al. ANNALS OF ONCOLOGY
- Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer
- (2013) Ben P. Haynes et al. BREAST CANCER RESEARCH AND TREATMENT
- PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
- (2013) Miguel Martín et al. BREAST CANCER RESEARCH AND TREATMENT
- ER and PR Immunohistochemistry and HER2 FISH versus Oncotype DX: Implications for Breast Cancer Treatment
- (2013) MiHee M. Park et al. Breast Journal
- The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
- (2013) P Dubsky et al. BRITISH JOURNAL OF CANCER
- BCL-2: A New Therapeutic Target in Estrogen Receptor-Positive Breast Cancer?
- (2013) Lesley-Ann Martin et al. CANCER CELL
- Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
- (2013) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway
- (2013) Xing-Hua Liao et al. FEBS Journal
- A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
- (2013) C.A. Drukker et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer
- (2013) Richard H de Boer et al. MEDICAL JOURNAL OF AUSTRALIA
- The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
- (2013) Berit Maria Müller et al. PLoS One
- Digital Quantification of Gene Expression in Sequential Breast Cancer Biopsies Reveals Activation of an Immune Response
- (2013) Rinath M. Jeselsohn et al. PLoS One
- EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
- (2012) P. Dubsky et al. ANNALS OF ONCOLOGY
- Reliability of core needle biopsy for determining ER and HER2 status in breast cancer
- (2012) T. J. A. Dekker et al. ANNALS OF ONCOLOGY
- PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
- (2012) Roy RL Bastien et al. BMC Medical Genomics
- Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial
- (2012) M. C. U. Cheang et al. CLINICAL CANCER RESEARCH
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
- (2012) S. K. Chia et al. CLINICAL CANCER RESEARCH
- Androgens Inhibit the Stimulatory Action of 17β-Estradiol on Normal Human Breast Tissue in Explant Cultures
- (2012) Natalija Eigėlienė et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Factors Associated With Receipt of Breast Cancer Adjuvant Chemotherapy in a Diverse Population-Based Sample
- (2012) Jennifer J. Griggs et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections
- (2012) Berit Maria Müller et al. JOURNAL OF CLINICAL PATHOLOGY
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
- (2012) LANCET ONCOLOGY
- Semi-quantitative immunohistochemical assay versus oncotype DX® qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study
- (2012) James A Kraus et al. MODERN PATHOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Correlation Between HER2 Determined by Fluorescence In Situ Hybridization and Reverse Transcription-Polymerase Chain Reaction of the Oncotype DX Test
- (2012) Leah Dvorak et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy
- (2011) M. C. Mathieu et al. ANNALS OF ONCOLOGY
- Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
- (2011) Gong Tang et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
- (2011) P-L Jerevall et al. BRITISH JOURNAL OF CANCER
- Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
- (2011) Pilar Eroles et al. CANCER TREATMENT REVIEWS
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study
- (2011) David J. Dabbs et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
- (2010) Michael Knauer et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
- (2010) Mothaffar F. Rimawi et al. CANCER
- Through a Glass Darkly: Advances in Understanding Breast Cancer Biology, 2000–2010
- (2010) Lisa A. Carey Clinical Breast Cancer
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression
- (2010) Atish Mukherjee et al. FASEB JOURNAL
- Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
- (2010) Frederick L. Baehner et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women
- (2010) Anita K. Dunbier et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
- (2010) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
- (2010) M. Beleut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amphiregulin Mediates Estrogen, Progesterone, and EGFR Signaling in the Normal Rat Mammary Gland and in Hormone-Dependent Rat Mammary Cancers
- (2010) Anastasia Kariagina et al. Hormones & Cancer
- The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
- (2009) S. Mook et al. ANNALS OF ONCOLOGY
- The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
- (2009) Marieke E. Straver et al. BREAST CANCER RESEARCH AND TREATMENT
- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse
- (2009) Rodrigo Fernandez-Valdivia et al. DEVELOPMENTAL BIOLOGY
- Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
- (2009) Florian Heitz et al. EUROPEAN JOURNAL OF CANCER
- Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
- (2009) Judith Hugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
- (2008) Stella Mook et al. BREAST CANCER RESEARCH AND TREATMENT
- Validation of 70-gene prognosis signature in node-negative breast cancer
- (2008) J. M. Bueno-de-Mesquita et al. BREAST CANCER RESEARCH AND TREATMENT
- Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
- (2008) B. S. Wittner et al. CLINICAL CANCER RESEARCH
- A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer
- (2008) X.-J. Ma et al. CLINICAL CANCER RESEARCH
- Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
- (2008) Lori J. Goldstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory
- (2008) Sunil S. Badve et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now